Five recommendations for loco-regional treatments of hepatocellular carcinoma during the COVID-19 pandemic
- PMID: 32561303
- PMCID: PMC7297168
- DOI: 10.1016/j.dld.2020.05.035
Five recommendations for loco-regional treatments of hepatocellular carcinoma during the COVID-19 pandemic
Conflict of interest statement
Declaration of Competing Interest The authors indicate no potential conflicts of interest.
Figures
Comment on
-
Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously.Int J Infect Dis. 2020 May;94:107-109. doi: 10.1016/j.ijid.2020.04.023. Epub 2020 Apr 18. Int J Infect Dis. 2020. PMID: 32315809 Free PMC article.
References
-
- Cabibbo G.E., Piscaglia F., Trevisani F., Daniele B., Belli G., Viganò L., Cappabianca S., Romanini L., Volterrani L., Cillo U. (2016) Raccomandazioni Multisocietarie Italiane (AISF, AIOM, IT IHPBA, SIC, SIRM, SITO) Per La Gestione Clinica Integrata Del Paziente Con Epatocarcinoma (HCC). pp 1–35. available atwww.webaisf.org/
-
- Forner A., Reig M., Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
